Clinical trial Recruiting at 1 site Observational Ages 18 and up

Identifying and treating renal artery stenosis in transplanted kidneys

Official title: Identification and Treatment of Renal Stenosis in Transplanted Kidneys

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06822205 · Data updated 2026-11-12

This study is testing if a new stenting treatment can help improve blood flow in transplanted kidneys for patients with narrowed renal arteries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJuly 7, 2023
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedFebruary 12, 2025
Trial IDNCT06822205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have undergone kidney transplantation and have been diagnosed with renal artery stenosis.

Probably not a fit

Patients who do not have renal artery stenosis or those who are not kidney transplant recipients may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on evaluating the efficacy and safety of endovascular treatment, specifically stenting, for patients with renal artery stenosis following kidney transplantation. It aims to assess technical success and graft salvage rates, as well as the complication rates associated with this treatment. The study includes a retrospective phase analyzing data from January 2020 to April 2023, followed by a prospective phase that will continue for two years starting in May 2023.

Why it matters

Potential benefit: If successful, this study could improve outcomes for kidney transplant patients by effectively treating renal artery stenosis and potentially preventing transplant failure.

How similar studies have gone: Previous studies have shown success with endovascular treatments for renal artery stenosis, indicating that this approach is supported by existing literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age greater than or equal to 18 years
* Indication of renal transplant and diagnosis of renal artery stenosis of the transplant
* Obtaining informed consent

Exclusion Criteria:

\-

Where it's running

  • IRCCS AOU di Bologna Policlinico di Sant'Orsola
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Mauro Gargiulo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Mauro Gargiulo, MD
  • Email: mauro.gargiulo2@unibo.it
  • Phone: 0512143288

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.